“As you may have noticed across the country, costs are going up. Unfortunately, Cost Plus Drugs is not immune to inflation,” a June 2 news release shared with Becker’s said.
In April, Mark Cuban floated this possibility during Becker’s annual conference because of “the way that pharmacy handling costs are going right now.”
“Our top priority is to continue to provide safe, affordable medications with transparent pricing,” the release said. “The fee increase will help maintain the level of service that you have come to expect from us.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.